Award

JP19ek0109394

Funder: Japan Agency for Medical Research and Development

Funded outputs count: 5

Funder award ID: JP19ek0109394

OpenAlex ID: G7993045613

An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) focusing on clinical and laboratory biomarkers

2020 · Junji Yamauchi, Natsumi Araya, et al. · Pharmacology & Therapeutics · 64

Use of cerebrospinal fluid CXCL10 and neopterin as biomarkers in HTLV-1-associated myelopathy/tropical spastic paraparesis treated with steroids

2019 · Junji Yamauchi, Tomoo Sato, et al. · Journal of Neurology Neurosurgery & Psychiatry · 19

Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan

2019 · Shuntaro Tsutsumi, Tomoo Sato, et al. · Orphanet Journal of Rare Diseases · 32

Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

2019 · Keiko Tamaki, Tomoo Sato, et al. · Frontiers in Microbiology · 30

Cerebrospinal fluid CXCL10 as a candidate surrogate marker for HTLV-1-associated myelopathy/tropical spastic paraparesis

· 玉木, 慶子 · Institutional Repositories DataBase (IRDB)